問卷

TPIDB > Principal Investigator

Principal Investigator


China Medical University Hospital (在職)

Division of General Surgery

Division of Colorectal Surgery

更新時間:2023-09-19

張伸吉
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

11Cases

2018-06-01 - 2027-06-30

Phase II/III

A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease
  • Condition/Disease

    Moderately to Severely Active Crohn's Disease

  • Test Drug

    guselkumab

Participate Sites
4Sites

Recruiting4Sites

1 2